Nath Bio-Genes (India) Ltd (NATHBIOGEN) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 628630,
    "name": "Nath Bio-Genes",
    "stock_name": "Nath Bio-Genes",
    "full_name": "Nath Bio-Genes (India) Ltd",
    "name_url": "stocks-analysis/nath-bio-genes",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "148.60",
    "chg": -0.3,
    "chgp": "-0.2%",
    "dir": -1,
    "prev_price": "148.90",
    "mcapval": "283.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 537291,
    "symbol": "NATHBIOGEN",
    "ind_name": "Other Agricultural Products",
    "ind_code": 107,
    "indexname": "",
    "isin": "INE448G01010",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "24.92 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/nath-bio-genes-628630-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Nath Bio-Genes Sees Revision in Market Assessment Amidst Challenging Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nath-bio-genes-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-technicals-3741042",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NathBioGenes_mojoScore_3741042.png",
        "date": "2025-12-02 10:09:46",
        "description": "Nath Bio-Genes has experienced a revision in its market evaluation, reflecting shifts in its fundamental and technical outlook. The company’s recent performance metrics and investor participation trends have contributed to this updated assessment, signalling caution for stakeholders in the Other Agricultural Products sector."
      },
      {
        "title": "Why is Nath Bio-Genes falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-nath-bio-genes-fallingrising-3726887",
        "imagepath": "",
        "date": "2025-11-25 01:10:02",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>The stock has been on a downward trajectory for the past two days, registering a cumulative loss of 7.01%. On the day in question, it touched an intraday low of ₹148, marking a 6.68% decline from previous levels. Notably, the weighted average price indicates that a larger volume of shares traded closer to this lower price point, signalling selling pressure among investors.</p>\n<p>Despite this, Nath Bio-Genes marginally outperformed its sector, Agri-Seeds, which fell by 6.09% on the same day. This relative outperformance, however, does little to offset the broader negative trend seen in the stock’s price.</p>\n<p><strong>Technical Indicators and Investor Sentiment</strong></p>\n<p>From a technical standpoint, the stock is trading below al..."
      },
      {
        "title": "Why is Nath Bio-Genes falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-nath-bio-genes-fallingrising-3716327",
        "imagepath": "",
        "date": "2025-11-19 23:02:02",
        "description": "As of 19-Nov, Nath Bio-Genes (India) Ltd is experiencing a decline in its stock price, currently at Rs 160.65, which reflects a decrease of 3.0 points or 1.83%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total decline of 3.72% during this period. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. In terms of performance against the benchmark, the stock has shown negative returns over various periods, including a year-to-date decline of 14.66% compared to a 9.02% increase in the Sensex. There is no information available regarding positive or negative factors that could influence the stock's recent movement.\n\nBroader Market Context: In the context of the broader market, the Agri-Seeds sector has also seen a downturn, with a decline of 5.53%. While Nath Bio-Genes has outperformed its sector by 3.5% toda..."
      },
      {
        "title": "Nath Bio-Genes Q2 FY26: Seasonal Slump Masks Underlying Growth as Stock Struggles",
        "link": "https://www.marketsmojo.com/news/result-analysis/nath-bio-genes-q2-fy26-seasonal-slump-masks-underlying-growth-as-stock-struggles-3716634",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/NathBioGenesInd_quaterlyResult_3716634.png",
        "date": "2025-11-15 10:04:35",
        "description": "Nath Bio-Genes (India) Ltd., a micro-cap agricultural products company with a market capitalisation of ₹320.00 crores, reported a consolidated net profit of ₹2.75 crores for Q2 FY26 (Jul-Sep'25), representing a sharp 92.62% quarter-on-quarter decline but a robust 147.75% year-on-year improvement. The dramatic sequential fall reflects the company's highly seasonal business model, where the first quarter typically captures the bulk of annual revenues during the peak agricultural season."
      },
      {
        "title": "How has been the historical performance of Nath Bio-Genes?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-nath-bio-genes-3699328",
        "imagepath": "",
        "date": "2025-11-13 23:32:10",
        "description": "Answer:\nThe historical performance of Nath Bio-Genes shows a consistent growth trend in net sales and profitability over the past four years.\n\nBreakdown:\nNath Bio-Genes has demonstrated a steady increase in net sales, rising from 278.36 crore in March 2022 to 364.91 crore in March 2025. Total operating income followed the same upward trajectory, reaching 364.91 crore in March 2025. The company's total expenditure, excluding depreciation, also increased, amounting to 315.11 crore in March 2025, up from 241.18 crore in March 2022. Operating profit, excluding other income, remained relatively stable, with a slight decrease to 49.80 crore in March 2025 from 49.86 crore in March 2024, while the overall operating profit (PBDIT) increased to 54.35 crore in March 2025. Profit before tax improved significantly from a loss of 63.43 crore in March 2022 to a profit of 40.04 crore in March 2025. Profit after tax also sa..."
      },
      {
        "title": "How has been the historical performance of Nath Bio-Genes?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-nath-bio-genes-3694063",
        "imagepath": "",
        "date": "2025-11-12 23:19:03",
        "description": "Answer:\nThe historical performance of Nath Bio-Genes shows a consistent growth trend in net sales and profitability over the past four years, culminating in the fiscal year ending March 2025.\n\nBreakdown:\nNath Bio-Genes reported net sales of 364.91 Cr in March 2025, an increase from 332.62 Cr in March 2024, 301.36 Cr in March 2023, and 278.36 Cr in March 2022. The total operating income mirrored this growth, reaching 364.91 Cr in March 2025. Total expenditure, excluding depreciation, also rose to 315.11 Cr in March 2025 from 282.76 Cr in March 2024, reflecting increased manufacturing and distribution expenses. Operating profit (PBDIT) was 54.35 Cr in March 2025, slightly up from 50.49 Cr in March 2024, while profit before tax improved to 40.04 Cr from 38.12 Cr. Profit after tax reached 38.06 Cr in March 2025, compared to 36.17 Cr in March 2024, indicating a positive trend in profitability. The earnings per s..."
      },
      {
        "title": "Nath Bio-Genes Faces Shift to Bearish Outlook Amid Declining Investor Confidence",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nath-bio-genes-stock-downgraded-to-strong-sell-amid-bearish-trends-3688596",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/NathBioGenesInd_mojoScore_3688596.png",
        "date": "2025-11-11 08:34:31",
        "description": "Nath Bio-Genes (India) has undergone a recent evaluation adjustment, reflecting a shift in its technical outlook. The company has reported a -10.61% return over the past year and a decline in institutional investor participation. Additionally, it has experienced a -0.69% CAGR growth in operating profits over five years."
      },
      {
        "title": "When is the next results date for Nath Bio-Genes?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-nath-bio-genes-3681195",
        "imagepath": "",
        "date": "2025-11-07 23:19:47",
        "description": "The next results date for Nath Bio-Genes is scheduled for 13 November 2025...."
      }
    ],
    "total": 130,
    "sid": "628630",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/nath-bio-genes-india-628630"
  },
  "announcements": [
    {
      "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
      "datetime": "31-Jan-2026",
      "details": "Issue of Duplicate Share Certificate",
      "source": "BSE"
    },
    {
      "caption": "Outcome Of Board Meeting",
      "datetime": "31-Jan-2026",
      "details": "Financial Results as on 31st December 2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "31-Jan-2026",
      "details": "Investor Presentation of Financial Results as on 31st December 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Nath Bio-Genes (India) Ltd has declared <strong>20%</strong> dividend, ex-date: 14 Aug 25",
          "dt": "2025-08-14",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Nath Bio-Genes Sees Revision in Market Assessment Amidst Challenging Fundamentals

2025-12-02 10:09:46

Nath Bio-Genes has experienced a revision in its market evaluation, reflecting shifts in its fundamental and technical outlook. The company’s recent performance metrics and investor participation trends have contributed to this updated assessment, signalling caution for stakeholders in the Other Agricultural Products sector.

Why is Nath Bio-Genes falling/rising?

2025-11-25 01:10:02

Recent Price Movement and Market Context The stock has been on a downward trajectory for the past two days, registering a cumulative loss of 7.01%. On the day in question, it touched an intraday low of ₹148, marking a 6.68% decline from previous levels. Notably, the weighted average price indicates that a larger volume of shares traded closer to this lower price point, signalling selling pressure among investors. Despite this, Nath Bio-Genes marginally outperformed its sector, Agri-Seeds, which fell by 6.09% on the same day. This relative outperformance, however, does little to offset the broader negative trend seen in the stock’s price. Technical Indicators and Investor Sentiment From a technical standpoint, the stock is trading below al...

Why is Nath Bio-Genes falling/rising?

2025-11-19 23:02:02

As of 19-Nov, Nath Bio-Genes (India) Ltd is experiencing a decline in its stock price, currently at Rs 160.65, which reflects a decrease of 3.0 points or 1.83%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total decline of 3.72% during this period. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. In terms of performance against the benchmark, the stock has shown negative returns over various periods, including a year-to-date decline of 14.66% compared to a 9.02% increase in the Sensex. There is no information available regarding positive or negative factors that could influence the stock's recent movement. Broader Market Context: In the context of the broader market, the Agri-Seeds sector has also seen a downturn, with a decline of 5.53%. While Nath Bio-Genes has outperformed its sector by 3.5% toda...

Nath Bio-Genes Q2 FY26: Seasonal Slump Masks Underlying Growth as Stock Struggles

2025-11-15 10:04:35

Nath Bio-Genes (India) Ltd., a micro-cap agricultural products company with a market capitalisation of ₹320.00 crores, reported a consolidated net profit of ₹2.75 crores for Q2 FY26 (Jul-Sep'25), representing a sharp 92.62% quarter-on-quarter decline but a robust 147.75% year-on-year improvement. The dramatic sequential fall reflects the company's highly seasonal business model, where the first quarter typically captures the bulk of annual revenues during the peak agricultural season.

How has been the historical performance of Nath Bio-Genes?

2025-11-13 23:32:10

Answer: The historical performance of Nath Bio-Genes shows a consistent growth trend in net sales and profitability over the past four years. Breakdown: Nath Bio-Genes has demonstrated a steady increase in net sales, rising from 278.36 crore in March 2022 to 364.91 crore in March 2025. Total operating income followed the same upward trajectory, reaching 364.91 crore in March 2025. The company's total expenditure, excluding depreciation, also increased, amounting to 315.11 crore in March 2025, up from 241.18 crore in March 2022. Operating profit, excluding other income, remained relatively stable, with a slight decrease to 49.80 crore in March 2025 from 49.86 crore in March 2024, while the overall operating profit (PBDIT) increased to 54.35 crore in March 2025. Profit before tax improved significantly from a loss of 63.43 crore in March 2022 to a profit of 40.04 crore in March 2025. Profit after tax also sa...

How has been the historical performance of Nath Bio-Genes?

2025-11-12 23:19:03

Answer: The historical performance of Nath Bio-Genes shows a consistent growth trend in net sales and profitability over the past four years, culminating in the fiscal year ending March 2025. Breakdown: Nath Bio-Genes reported net sales of 364.91 Cr in March 2025, an increase from 332.62 Cr in March 2024, 301.36 Cr in March 2023, and 278.36 Cr in March 2022. The total operating income mirrored this growth, reaching 364.91 Cr in March 2025. Total expenditure, excluding depreciation, also rose to 315.11 Cr in March 2025 from 282.76 Cr in March 2024, reflecting increased manufacturing and distribution expenses. Operating profit (PBDIT) was 54.35 Cr in March 2025, slightly up from 50.49 Cr in March 2024, while profit before tax improved to 40.04 Cr from 38.12 Cr. Profit after tax reached 38.06 Cr in March 2025, compared to 36.17 Cr in March 2024, indicating a positive trend in profitability. The earnings per s...

Nath Bio-Genes Faces Shift to Bearish Outlook Amid Declining Investor Confidence

2025-11-11 08:34:31

Nath Bio-Genes (India) has undergone a recent evaluation adjustment, reflecting a shift in its technical outlook. The company has reported a -10.61% return over the past year and a decline in institutional investor participation. Additionally, it has experienced a -0.69% CAGR growth in operating profits over five years.

When is the next results date for Nath Bio-Genes?

2025-11-07 23:19:47

The next results date for Nath Bio-Genes is scheduled for 13 November 2025....

View All News